Cargando…
Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer relapse. This resistance mostly originates from rare, but impactful presence of cancer stem cells (CSCs). Ability to self-renewal and differentiation into heterogeneous cancer cells, and harboring morphologicall...
Autores principales: | Rezayatmand, Hamed, Razmkhah, Mahboobeh, Razeghian-Jahromi, Iman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066908/ https://www.ncbi.nlm.nih.gov/pubmed/35505363 http://dx.doi.org/10.1186/s13287-022-02856-6 |
Ejemplares similares
-
Mesenchymal stem cells: amazing remedies for bone and cartilage defects
por: Kangari, Parisa, et al.
Publicado: (2020) -
Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy
por: Razeghian-Jahromi, Iman, et al.
Publicado: (2021) -
Is It All About Endothelial Dysfunction and Thrombosis Formation? The
Secret of COVID-19
por: Elyaspour, Zahra, et al.
Publicado: (2021) -
Composition, Biogenesis, and Role of Exosomes in Tumor Development
por: Moeinzadeh, Leila, et al.
Publicado: (2022) -
Immune system and atherosclerosis: Hostile or friendly
relationship
por: Razeghian-Jahromi, Iman, et al.
Publicado: (2022)